Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$1.13 $0 (0.18%) RKDA stock closing price Dec 02, 2016 (Closing)

The fundamental analysis of this company requires a thorough look at Arcadia Biosciences balance sheet. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. The Arcadia Biosciences balance sheet for 2015 shows total assets of $74.24M. Arcadia Biosciences revenue was $5.41M and Arcadia Biosciences operating cash flow was $-15.1M for the same year. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Marketable Securities26.27M--
Raw Materials---
Work In Progress---
Finished Goods---
Notes Receivable---
Other Current Assets0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
Property Plant & Equipment5.24M5.38M5.27M
Accumulated Depreciation4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances19.74M0.5M1.43M
Other Non-Current Assets1.86M2.14M2.53M
Deferred Charges---
Deposits & Other Assets0.02M2.81M0.06M
Arcadia Biosciences Total Assets
Notes Payable-5.6M4.56M
Accounts Payable2.42M3.19M2.51M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income2.63M3.63M4.37M
Convertible Debt---
Long-Term Debt24.93M8.86M9.92M
Non-Current Capital Leases---
Other Long-Term Liabilities3M3M3M
Arcadia Biosciences Total Liabilities
Minority Interest---
Preferred Stock-82.88M-
Common Stock Net0.04M--
Capital Surplus172.22M29.2M78.33M
Retained Earnings-131.92M-113.97M-95.63M
Treasury Stock---
Other Liabilities-0.11M--
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

Looking at Arcadia Biosciences historical stock prices and the current Arcadia Biosciences stock price can tell you how the stock price has moved, whereas the Arcadia Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for RKDA stock as of year is $74.24M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Arcadia Biosciences is $34.01M. Shareholders' equity comes under liabilities as it is money the company owes the holders of RKDA stock.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio